Excessive IL-22 in the cancer microenvironment leads to tumor growth with the activation of the STAT3 pathway [203], and the epigenetic activation of genes with a STAT3-dependent pathway maintains the CRC stem cells [59]. The gene discussed is IL22; the disease is colorectal carcinoma.